Research Article

Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of Astragalus membranaceus in the Treatment of Gastric Ulcer

Table 1

Chemical properties of bioactive ingredients.

CodeMol. IDMolecule nameOB (%)DL

HQ1MOL000211Mairin55.380.78
HQ2MOL000239Jaranol50.830.29
HQ3MOL000296Hederagenin36.910.75
HQ4MOL000033(3S,8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-[(2R,5S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol36.230.78
HQ5MOL000354Isorhamnetin49.600.31
HQ6MOL0003713,9-Di-O-methylnissolin53.740.48
HQ7MOL0003745′-Hydroxyiso-muronulatol-2′,5′-di-O-glucoside41.720.69
HQ8MOL0003787-O-Methylisomucronulatol74.690.30
HQ9MOL0003799,10-Dimethoxypterocarpan-3-O-β-D-glucoside36.740.92
HQ10MOL000380(6aR,11aR)-9,10-Dimethoxy-6a,11a-dihydro-6H-benzofurano [3,2-c]chromen-3-ol64.260.42
HQ11MOL000387Bifendate31.100.67
HQ12MOL000392Formononetin69.670.21
HQ13MOL000417Calycosin47.750.24
HQ14MOL000422Kaempferol41.880.24
HQ15MOL000433FA68.960.71
HQ16MOL0004421,7-Dihydroxy-3,9-dimethoxy pterocarpene39.050.48
HQ17MOL000098Quercetin46.430.28
HQ18MOL000391Ononin11.520.78
HQ19MOL000398Isoflavanone109.990.30
HQ20MOL000438(3R)-3-(2-Hydroxy-3,4-dimethoxyphenyl)chroman-7-ol67.670.26
HQ21MOL000439Isomucronulatol-7,2′-di-O-glucosiole49.280.62
HQ22MOL000405Astragaloside III31.830.10
HQ23MOL000407Astragaloside IV22.500.15